ZS Pharma
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, ZS Pharma sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
ZS Pharma: 8 sponsored US clinical trials, none currently recruiting.
ZS Pharma sponsors 8 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 5 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hyperkalemia, with 1 trials.
Upper-quartile sponsor footprint
ZS Pharma sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
8 total, page 1 of 1
REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study
NCT02607085
POtassium and Cardiac Rhythm Trends in MaintENance HemoDialysis: A Multicenter, Prospective, Observational Study
NCT02609841
Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months
NCT02163499
Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia.
NCT02107092
Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.
NCT02088073
Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia
NCT01866709
Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia
NCT01737697
Safety & Efficacy of Zirconium Silicate in Chronic Kidney Disease or Moderate Kidney Dysfunction With Mild Hyperkalemia
NCT01493024
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 4 |
| Phase 4 | 1 |
Therapeutic Areas
How the ZS Pharma archive is shaped
8 indexed studies, none listed as recruiting (0% open); 7 completed (88%).
Phase mix: 5 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Hyperkalemia (1 trial), 2 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
ZS Pharma: archived-pipeline peers nationwide
Peers matched on 8 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
ZS Pharma sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 archived trials
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this ZS Pharma page
8 registered trials is a research-attention snapshot, not an endorsement of ZS Pharma or any single study.
- None of ZS Pharma's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Hyperkalemia is the condition ZS Pharma studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hyperkalemia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
ZS Pharma pipeline card: 8 registered trials from official public datasets.Report a data error.